Another important mechanism by which cancer cells inhibit T cell effector functions is through the expression of ligands to immune checkpoint molecules such as programmed cell death 1 (PD-1) and cytotoxic T lymphocyte-associated protein 4 (CTLA-4), which are highly upregulated on the surface of activated T cells. The gene discussed is CTLA4; the disease is cancer.